House lawmakers to discuss 340B legislation this week as tensions build
Big Pharma and hospitals are coming head-to-head over the 340B drug reimbursement program with substantial changes at stake.Capitol Hill lawmakers who want to enact a moratorium on CMS’ imminent Medicare payment cuts to 340B hospitals face mounting pressure to include reporting and transparency measures; the pressure comes from inside their ranks and from the drug industry.
